PF-06409577
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06409577, covering 2015-07-20 to 2015-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects [Phase 1]